Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
TECHNETIUM TEBOROXIME
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
TECHNETIUM TEBOROXIME
×
Maximum Phase:
4
First Approval:
1990
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H29BClN6O6Tc
Molecular Weight:
581.74
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TECHNETIUM TC 99M TEBOROXIME
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
TECHNETIUM TC 99M TEBOROXIME
×
Maximum Phase:
4
First Approval:
1990
UNII:
UT0WHJ4951
Molecule Type:
Small molecule
Molecular Formula:
C19H29BClN6O6Tc
Molecular Weight:
582.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ISRADIPINE
(1990)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Cardiovascular Diseases; Hypertension
ISRADIPINE
×
Maximum Phase:
4
First Approval:
1990
UNII:
YO1UK1S598
Molecule Type:
Small molecule
Molecular Formula:
C19H21N3O5
Molecular Weight:
371.39
AlogP:
2.58
PSA:
103.55
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IDARUBICIN HYDROCHLORIDE
(1990)
Small molecule
DNA inhibitor
INJECTION
Approved
Leukemia, Myeloid, Acute
IDARUBICIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
5VV3MDU5IE
Molecule Type:
Small molecule
Molecular Formula:
C26H28ClNO9
Molecular Weight:
533.96
AlogP:
1.02
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
CETYL ALCOHOL
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
CETYL ALCOHOL
×
Maximum Phase:
4
First Approval:
1990
UNII:
936JST6JCN
Molecule Type:
Small molecule
Molecular Formula:
C16H34O
Molecular Weight:
242.45
AlogP:
5.46
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
14.0
Source:
HALOBETASOL PROPIONATE
(1990)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Psoriasis; Skin Diseases
HALOBETASOL PROPIONATE
×
Maximum Phase:
4
First Approval:
1990
UNII:
91A0K1TY3Z
Molecule Type:
Small molecule
Molecular Formula:
C25H31ClF2O5
Molecular Weight:
484.97
AlogP:
4.05
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
REMOXIPRIDE HYDROCHLORIDE
(1990)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Approved
Unknown
REMOXIPRIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
MH4OU8RWCW
Molecule Type:
Small molecule
Molecular Formula:
C16H26BrClN2O4
Molecular Weight:
425.75
AlogP:
2.68
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
6.0
Source:
DOXAZOSIN MESYLATE
(1990)
Small molecule
Adrenergic receptor alpha-1 antagonist
ORAL
Approved
Hypertension; Myocardial Infarction; Prostatic Hyperplasia
DOXAZOSIN MESYLATE
×
Maximum Phase:
4
First Approval:
1990
UNII:
86P6PQK0MU
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O8S
Molecular Weight:
547.59
AlogP:
1.72
PSA:
112.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IDARUBICIN
(1990)
Small molecule
Unknown
Unknown
Approved
Neoplasms
IDARUBICIN
×
Maximum Phase:
4
First Approval:
1990
UNII:
ZRP63D75JW
Molecule Type:
Small molecule
Molecular Formula:
C26H27NO9
Molecular Weight:
497.5
AlogP:
1.02
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
OLSALAZINE
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
OLSALAZINE
×
Maximum Phase:
4
First Approval:
1990
UNII:
ULS5I8J03O
Molecule Type:
Small molecule
Molecular Formula:
C14H10N2O6
Molecular Weight:
302.24
AlogP:
2.91
PSA:
139.78
HBD:
4.0
HBA:
#RotB:
4.0
Source:
ACETAZOLAMIDE SODIUM
(1990)
Small molecule
Carbonic anhydrase I inhibitor
INJECTION
Approved
Edema; Glaucoma; Glaucoma, Angle-Closure; Seizures
ACETAZOLAMIDE SODIUM
×
Maximum Phase:
4
First Approval:
1990
UNII:
429ZT169UH
Molecule Type:
Small molecule
Molecular Formula:
C4H5N4NaO3S2
Molecular Weight:
244.23
AlogP:
-0.86
PSA:
115.04
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DAPIPRAZOLE
(1990)
Small molecule
Unknown
Unknown
Approved
Glaucoma
DAPIPRAZOLE
×
Maximum Phase:
4
First Approval:
1990
UNII:
5RNZ8GJO7K
Molecule Type:
Small molecule
Molecular Formula:
C19H27N5
Molecular Weight:
325.46
AlogP:
2.29
PSA:
37.19
HBD:
0.0
HBA:
#RotB:
4.0
Source:
REMOXIPRIDE
(1990)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Approved
Psychotic Disorders
REMOXIPRIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
0223RD59PE
Molecule Type:
Small molecule
Molecular Formula:
C16H23BrN2O3
Molecular Weight:
371.28
AlogP:
2.68
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OLSALAZINE SODIUM
(1990)
Small molecule
Arachidonate 5-lipoxygenase inhibitor
ORAL
Approved
Colitis, Ulcerative
OLSALAZINE SODIUM
×
Maximum Phase:
4
First Approval:
1990
UNII:
Y7JEW0XG7I
Molecule Type:
Small molecule
Molecular Formula:
C14H8N2Na2O6
Molecular Weight:
346.21
AlogP:
2.91
PSA:
139.78
HBD:
4.0
HBA:
#RotB:
4.0
Source:
MORICIZINE HYDROCHLORIDE
(1990)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Unknown
MORICIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
71OK3Z1ESP
Molecule Type:
Small molecule
Molecular Formula:
C22H26ClN3O4S
Molecular Weight:
463.99
AlogP:
4.11
PSA:
71.11
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DAPIPRAZOLE HYDROCHLORIDE
(1990)
Small molecule
Alpha-1a adrenergic receptor antagonist
OPHTHALMIC
Approved
Glaucoma, Open-Angle; Mydriasis
DAPIPRAZOLE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
DS9UJN1I0X
Molecule Type:
Small molecule
Molecular Formula:
C19H28ClN5
Molecular Weight:
361.92
AlogP:
2.29
PSA:
37.19
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FLUCONAZOLE
(1990)
Small molecule
Cytochrome P450 51 inhibitor
INJECTION; ORAL
Approved
Candidiasis; Candidiasis, Vulvovaginal; Meningitis, Cryptococcal; Urinary Tract Infections
FLUCONAZOLE
×
Maximum Phase:
4
First Approval:
1990
UNII:
8VZV102JFY
Molecule Type:
Small molecule
Molecular Formula:
C13H12F2N6O
Molecular Weight:
306.28
AlogP:
0.74
PSA:
81.65
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DOXAZOSIN
(1990)
Small molecule
Unknown
Unknown
Approved
Hypertension
DOXAZOSIN
×
Maximum Phase:
4
First Approval:
1990
UNII:
NW1291F1W8
Molecule Type:
Small molecule
Molecular Formula:
C23H25N5O5
Molecular Weight:
451.48
AlogP:
1.72
PSA:
112.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FLUTICASONE PROPIONATE
(1990)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL; TOPICAL
Approved
Asthma; Bronchitis, Chronic; Dermatitis, Atopic; Emphysema; Lung Diseases, Obstructive; Nasal Obstruction; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal; Skin Diseases
FLUTICASONE PROPIONATE
×
Maximum Phase:
4
First Approval:
1990
UNII:
O2GMZ0LF5W
Molecule Type:
Small molecule
Molecular Formula:
C25H31F3O5S
Molecular Weight:
500.58
AlogP:
4.43
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BEPRIDIL HYDROCHLORIDE
(1990)
Small molecule
Voltage-gated calcium channel blocker
ORAL
Approved
Unknown
BEPRIDIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
4W2P15D93M
Molecule Type:
Small molecule
Molecular Formula:
C24H37ClN2O2
Molecular Weight:
421.03
AlogP:
4.83
PSA:
15.71
HBD:
0.0
HBA:
#RotB:
10.0
Source:
ALTRETAMINE
(1990)
Small molecule
DNA inhibitor
ORAL
Approved
Neoplasms
ALTRETAMINE
×
Maximum Phase:
4
First Approval:
1990
UNII:
Q8BIH59O7H
Molecule Type:
Small molecule
Molecular Formula:
C9H18N6
Molecular Weight:
210.28
AlogP:
0.07
PSA:
48.39
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MORICIZINE
(1990)
Small molecule
Unknown
Unknown
Approved
Arrhythmias, Cardiac
MORICIZINE
×
Maximum Phase:
4
First Approval:
1990
UNII:
2GT1D0TMX1
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3O4S
Molecular Weight:
427.53
AlogP:
4.11
PSA:
71.11
HBD:
1.0
HBA:
#RotB:
5.0
Source:
EFLORNITHINE HYDROCHLORIDE
(1990)
Small molecule
Ornithine decarboxylase inhibitor
Unknown
Approved
Unknown
EFLORNITHINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1990
UNII:
4NH22NDW9H
Molecule Type:
Small molecule
Molecular Formula:
C6H15ClF2N2O3
Molecular Weight:
236.65
AlogP:
-0.23
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
GLUCONOLACTONE
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
GLUCONOLACTONE
×
Maximum Phase:
4
First Approval:
1990
UNII:
WQ29KQ9POT
Molecule Type:
Small molecule
Molecular Formula:
C6H10O6
Molecular Weight:
178.14
AlogP:
-3.01
PSA:
107.22
HBD:
4.0
HBA:
#RotB:
1.0
Source:
PODOFILOX
(1990)
Small molecule
Unknown
TOPICAL
Approved
Carcinoma, Squamous Cell; Condylomata Acuminata; Virus Diseases
PODOFILOX
×
Maximum Phase:
4
First Approval:
1990
UNII:
L36H50F353
Molecule Type:
Small molecule
Molecular Formula:
C22H22O8
Molecular Weight:
414.41
AlogP:
2.41
PSA:
92.68
HBD:
1.0
HBA:
#RotB:
4.0
Source:
OFLOXACIN
(1990)
Small molecule
Bacterial DNA gyrase inhibitor
INJECTION; OPHTHALMIC; ORAL; OTIC
Approved
Bacterial Infections; Eye Infections; Infections
OFLOXACIN
×
Maximum Phase:
4
First Approval:
1990
UNII:
A4P49JAZ9H
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.54
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PIPECURONIUM
(1990)
Small molecule
Unknown
Unknown
Approved
Unknown
PIPECURONIUM
×
Maximum Phase:
4
First Approval:
1990
UNII:
1N3O74HM92
Molecule Type:
Small molecule
Molecular Formula:
C35H62N4O4+2
Molecular Weight:
602.91
AlogP:
3.63
PSA:
59.08
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LEVAMISOLE
(1990)
Small molecule
Unknown
Unknown
Approved
Helminthiasis
LEVAMISOLE
×
Maximum Phase:
4
First Approval:
1990
UNII:
2880D3468G
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2S
Molecular Weight:
204.3
AlogP:
2.15
PSA:
15.6
HBD:
0.0
HBA:
#RotB:
1.0
Source:
COLFOSCERIL PALMITATE
(1990)
Small molecule
Lung surfactant
Unknown
Approved
Respiratory Distress Syndrome, Newborn; Respiratory Tract Diseases
COLFOSCERIL PALMITATE
×
Maximum Phase:
4
First Approval:
1990
UNII:
319X2NFW0A
Molecule Type:
Small molecule
Molecular Formula:
C40H80NO8P
Molecular Weight:
734.05
AlogP:
10.61
PSA:
111.19
HBD:
0.0
HBA:
#RotB:
38.0
Source:
BENAZEPRIL
(1991)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
BENAZEPRIL
×
Maximum Phase:
4
First Approval:
1991
UNII:
UDM7Q7QWP8
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O5
Molecular Weight:
424.5
AlogP:
2.57
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
DOXACURIUM
(1991)
Small molecule
Unknown
Unknown
Approved
Unknown
DOXACURIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
P40015Y3WW
Molecule Type:
Small molecule
Molecular Formula:
C56H78N2O16+2
Molecular Weight:
1035.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ETODOLAC
(1991)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Acute Pain; Arthritis, Juvenile; Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
ETODOLAC
×
Maximum Phase:
4
First Approval:
1991
UNII:
2M36281008
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO3
Molecular Weight:
287.36
AlogP:
3.38
PSA:
62.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FOSINOPRIL SODIUM
(1991)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Heart Failure; Hypertension
FOSINOPRIL SODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
NW2RTH6T2N
Molecule Type:
Small molecule
Molecular Formula:
C30H45NNaO7P
Molecular Weight:
585.65
AlogP:
6.12
PSA:
110.21
HBD:
1.0
HBA:
#RotB:
14.0
Source:
PRAVASTATIN SODIUM
(1991)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hypothyroidism; Myocardial Infarction; Nephrotic Syndrome
PRAVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
3M8608UQ61
Molecule Type:
Small molecule
Molecular Formula:
C23H35NaO7
Molecular Weight:
446.52
AlogP:
2.44
PSA:
124.29
HBD:
4.0
HBA:
#RotB:
10.0
Source:
CEFPROZIL
(1991)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bacterial Infections; Bronchitis, Chronic; Infections; Otitis Media; Pharyngitis; Sinusitis; Tonsillitis
CEFPROZIL
×
Maximum Phase:
4
First Approval:
1991
UNII:
4W0459ZA4V
Molecule Type:
Small molecule
Molecular Formula:
C18H21N3O6S
Molecular Weight:
407.45
AlogP:
0.71
PSA:
132.96
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PREDNICARBATE
(1991)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Adrenal Hyperplasia, Congenital; Anemia; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Brain Neoplasms; Bursitis; Conjunctivitis, Allergic; Dermatitis, Atopic; Endocrine System Diseases; Inflammation; Multiple Sclerosis; Neoplasms; Osteoarthritis; Peptic Ulcer; Rhinitis, Allergic; Skin Diseases; Spondylitis; Tenosynovitis; Uveitis, Posterior
PREDNICARBATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
V901LV1K7D
Molecule Type:
Small molecule
Molecular Formula:
C27H36O8
Molecular Weight:
488.58
AlogP:
3.7
PSA:
116.2
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
37
38
39
40
41
42
43
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA